MedTrace Logo

Taurolidine Lock in Long Term Parenteral Nutrition

NCT02009189 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-12-11

No results posted yet for this study

Summary

Taurolidine alone or in combination with citrate have been proposed for locking the catheter to reduce the number of catheter infections. As there is not enough evidence to give recommendations in this regard, the study tested the hipothesis that taurolidine improves the outcome of long term paretneral nutrition.

Conditions

  • Home Parenteral Nutrition
  • Central Venous Catheter

Interventions

DRUG

2% Taurolidine Lock

Catheter lock with 2% Taurolidine

DRUG

1.35% Taurolidine

Catheter lock with 1.35% Taurolidine + citrate

Sponsors & Collaborators

  • Stanley Dudrick's Memorial Hospital

    lead OTHER

Principal Investigators

  • Stanislaw Klek, Assoc Prof · Stanley Dudrick's Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02009189 on ClinicalTrials.gov